TL;DR
This paper presents the development and characterization of novel aspirin-inducible biosensors in E. coli and SimCells. These biosensors, based on the Pseudomonas putida SalR regulatory system, offer precise control over gene expression in response to aspirin, paving the way for advanced applications in bacterial therapy and environmental monitoring.
What Problem Does This Paper Address?
The development of synthetic gene circuits for therapeutic and diagnostic applications in biological systems requires precise control over gene expression. Ideally, these systems should be inducible by safe, readily available molecules that are not naturally abundant in the body to avoid unwanted background activation. Aspirin, a widely used and safe analgesic, presents an attractive candidate for such an inducer. However, engineering reliable and sensitive aspirin-inducible systems has been a challenge. This paper addresses this by characterizing and optimizing the Pseudomonas putida SalR regulatory system for use in E. coli and a novel cell-free chassis, SimCells, aiming to create robust and controllable biosensors.
Methods
The researchers employed a combination of molecular biology techniques and computational modeling. Key methods include:
- Gene Circuit Design and Construction: They designed two main circuit architectures: a Simple Regulatory System (SRS) and a Positive Autoregulatory System (PAR). These circuits were engineered by cloning and modifying the salR gene and its associated promoter (Psal) from Acinetobacter baylyi ADP1 into E. coli.
- Mutagenesis: Specific mutations were introduced into the SalR protein's DNA-binding domain (DBD) and chemical recognition domain (CRD) to investigate its regulatory mechanism.
- Flow Cytometry and Fluorescence Microscopy: These techniques were used to measure GFP expression at the single-cell level, allowing for detailed analysis of circuit behavior and heterogeneity.
- Mathematical Modeling: A deterministic mathematical model was developed to simulate the SalR regulatory mechanism, incorporating a competitive binding hypothesis between inactive (SalRᵢ) and active (SalRₐ) forms of the protein. This model was used to predict circuit performance and validate experimental findings.
- Chassis Development: The developed gene circuits were tested in two distinct E. coli chassis: the probiotic strain E. coli Nissle 1917 (EcN) and SimCells (chromosome-free E. coli minicells).
- Raman Spectroscopy: Used to investigate the metabolic activity of cells in response to aspirin and its potential metabolites.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Competitive Binding Mechanism: The study strongly supports a "sliding dimer" mechanism where both inactive (SalRᵢ) and active (SalRₐ) forms of the SalR protein can bind to the Psal promoter. This competitive binding is crucial for regulating gene expression.
- Weak SalR Expression Enhances Sensitivity: Counterintuitively, a weak expression of SalR in the SRS system led to improved inducible strength. This aligns with the competitive binding hypothesis, suggesting that lower SalRᵢ levels reduce repression, allowing for greater activation by SalRₐ.
- PAR System for Fine-Tuning: The Positive Autoregulatory System (PAR) effectively fine-tunes SalR levels through a feedback loop, leading to stronger overall induction and a broader dynamic range compared to the SRS.
- Aspirin as a Safe and Effective Inducer: The developed systems demonstrate dose-dependent induction with aspirin in the low micromolar range (0.05-10 µM), significantly lower than the safe therapeutic dosage in humans. This highlights aspirin's potential as a safe and specific inducer.
- Chassis Versatility: The aspirin-inducible biosensors function effectively in both the probiotic strain E. coli Nissle 1917 and the novel SimCell chassis, demonstrating the modularity and robustness of the developed gene circuits.
Key Results
- Dose-Dependent Induction: Both SRS and PAR systems showed a clear dose-dependent response to aspirin in the range of 0.05-10 µM.
- SRS vs. PAR Performance:
- SRS exhibited lower background leakiness but required a higher induction threshold (2.5 µM aspirin).
- PAR showed stronger overall GFP expression and a lower induction threshold (0.05 µM aspirin) but had higher leaky expression.
- Mathematical Model Validation: The developed mathematical model accurately reproduced experimental results and predicted the performance of new gene circuit designs.
- Functional in Probiotic and SimCells: The aspirin-inducible systems were successfully implemented and functional in E. coli Nissle 1917 and SimCells.
- Aspirin Metabolism: Raman spectroscopy suggested that E. coli can metabolize aspirin into acetate and salicylate, with salicylate likely being the direct activator of SalR.
Limitations and Future Work
- Aspirin Transport in E. coli: The exact mechanism and efficiency of aspirin/salicylate transport into E. coli remain unclear, although it's hypothesized to involve efflux systems. Further investigation into specific transport proteins or mechanisms is warranted.
- Metabolic Breakdown in EcN: The observation of a secondary metabolic breakdown of aspirin in E. coli Nissle 1917, not previously reported, suggests potential for further metabolic engineering or understanding of this strain.
- SimCell Growth Kinetics: While SimCells demonstrated low background leakiness, their growth kinetics in response to aspirin were not extensively studied in this paper.
- Future Work: The authors suggest that these well-characterized and modular aspirin-inducible gene circuits can serve as valuable "biobricks" for bacterial therapy in environmental and medical applications, including drug delivery and diagnostics. The mathematical modeling framework also provides a tool for designing future synthetic biological systems.
Summary updated